Cerity Partners’s PolyPid PYPD Stock Holding History

Cerity Partners’s Portfolio PYPD Stock Details PYPD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-624	Closed	-$6.83K	–	1650
2023 Q2	$6.83K	Hold	624	–	–	﹤0.01%	1617
2023 Q1	$8.61K	Hold	624	–	–	﹤0.01%	1836
2022 Q4	$13.1K	Hold	624	–	–	﹤0.01%	1465
2022 Q3	$22K	Hold	624	–	–	﹤0.01%	1163
2022 Q2	$87K	Buy	+624	New	+$93.4K	﹤0.01%	1138

Other funds holding PYPD

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cerity Partners's PYPD Position: Q3 2023 in Review

Cerity Partners sold out of PolyPid (PYPD) in Q3 2023, closing a stake of 624 shares — an estimated $6.83K sold.

Cerity Partners first reported a position in PYPD in Q2 2022 and held it in 5 quarters. The position peaked at $87K in Q2 2022. 4 funds tracked by Wall St. Rank hold PYPD as of Q3 2023.

Cerity Partners reported no remaining PolyPid position as of Q3 2023 after selling out during the quarter.
Cerity Partners sold 624 PolyPid shares in Q3 2023, an estimated $6.83K.
Cerity Partners first reported a position in PolyPid in Q2 2022 and held it in 5 quarters.
Cerity Partners's PolyPid position peaked at $87K in Q2 2022.
4 funds tracked by Wall St. Rank held PolyPid as of Q3 2023.

Based on Cerity Partners's 13F filing for Q3 2023, filed 14 Nov 2023.